These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33918449)

  • 1. Estimating the Oral Absorption from Self-Nanoemulsifying Drug Delivery Systems Using an In Vitro Lipolysis-Permeation Method.
    Klitgaard M; Müllertz A; Berthelsen R
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assessment of in vitro lipolysis and permeation in the mucus-PVPA model to predict oral absorption of a poorly water soluble drug in SNEDDSs.
    Falavigna M; Brurok S; Klitgaard M; Flaten GE
    Int J Pharm; 2021 Mar; 596():120258. PubMed ID: 33486034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Oral Absorption of fenofibrate in Lipid-Based Drug Delivery Systems by Combining In Vitro Lipolysis with the Mucus-PVPA Permeability Model.
    Falavigna M; Klitgaard M; Berthelsen R; Müllertz A; Flaten GE
    J Pharm Sci; 2021 Jan; 110(1):208-216. PubMed ID: 32916137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation.
    Larsen AT; Ohlsson AG; Polentarutti B; Barker RA; Phillips AR; Abu-Rmaileh R; Dickinson PA; Abrahamsson B; Ostergaard J; Müllertz A
    Eur J Pharm Sci; 2013 Jan; 48(1-2):339-50. PubMed ID: 23178440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous lipolysis/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems.
    Bibi HA; Holm R; Bauer-Brandl A
    Eur J Pharm Biopharm; 2017 Aug; 117():300-307. PubMed ID: 28478159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of cinnarizine in dogs: effect of SNEDDS loading level and correlation with cinnarizine solubilization during in vitro lipolysis.
    Larsen AT; Åkesson P; Juréus A; Saaby L; Abu-Rmaileh R; Abrahamsson B; Østergaard J; Müllertz A
    Pharm Res; 2013 Dec; 30(12):3101-13. PubMed ID: 23949249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of drug load and physical form of cinnarizine in new SNEDDS dosing regimens: in vivo and in vitro evaluations.
    Siqueira SD; Müllertz A; Gräeser K; Kasten G; Mu H; Rades T
    AAPS J; 2017 Mar; 19(2):587-594. PubMed ID: 28070714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Digestion-In Situ Absorption Setup Employing a Physiologically Relevant Value of the Membrane Surface Area/Volume Ratio for Evaluating Performance of Lipid-Based Formulations: A Comparative Study with an In Vitro Digestion-Permeation Model.
    Tanaka Y; Arai H; Hidaka A; Noda S; Imai K; Tsujisawa F; Yagi H; Sakuma S
    Mol Pharm; 2024 Jul; 21(7):3459-3470. PubMed ID: 38809159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring impact of supersaturated lipid-based drug delivery systems of celecoxib on in vitro permeation across Permeapad
    Ilie AR; Griffin BT; Brandl M; Bauer-Brandl A; Jacobsen AC; Vertzoni M; Kuentz M; Kolakovic R; Holm R
    Eur J Pharm Sci; 2020 Sep; 152():105452. PubMed ID: 32622980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.
    Kollipara S; Gandhi RK
    Acta Pharm Sin B; 2014 Oct; 4(5):333-49. PubMed ID: 26579403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDSs) for senicapoc.
    Buya AB; Ucakar B; Beloqui A; Memvanga PB; Préat V
    Int J Pharm; 2020 Apr; 580():119180. PubMed ID: 32135227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ability of two in vitro lipolysis models reflecting the human and rat gastro-intestinal conditions to predict the in vivo performance of SNEDDS dosing regimens.
    Siqueira Jørgensen SD; Al Sawaf M; Graeser K; Mu H; Müllertz A; Rades T
    Eur J Pharm Biopharm; 2018 Mar; 124():116-124. PubMed ID: 29288805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipolysis-Permeation Setup for Simultaneous Study of Digestion and Absorption in Vitro.
    Keemink J; Mårtensson E; Bergström CAS
    Mol Pharm; 2019 Mar; 16(3):921-930. PubMed ID: 30628771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Cellular Monolayers and an Artificial Membrane as Absorptive Membranes in the in vitro Lipolysis-permeation Assay.
    Keemink J; Hedge OJ; Bianco V; Hubert M; Bergström CAS
    J Pharm Sci; 2022 Jan; 111(1):175-184. PubMed ID: 34516987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluations of the performance of an indirubin derivative, formulated in four different self-emulsifying drug delivery systems.
    Heshmati N; Cheng X; Dapat E; Sassene P; Eisenbrand G; Fricker G; Müllertz A
    J Pharm Pharmacol; 2014 Nov; 66(11):1567-75. PubMed ID: 24961657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization.
    Larsen AT; Ogbonna A; Abu-Rmaileh R; Abrahamsson B; Ostergaard J; Müllertz A
    Pharmaceutics; 2012 Dec; 4(4):641-65. PubMed ID: 24300374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
    Dahan A; Hoffman A
    Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate oral absorption from SNEDDS and super-SNEDDS is not significantly affected by lipase inhibition in rats.
    Michaelsen MH; Siqueira Jørgensen SD; Abdi IM; Wasan KM; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2019 Sep; 142():258-264. PubMed ID: 31276759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the Molecular Interactions Occurring during Drug Precipitation of Weak Bases from Lipid-Based Formulations: A Case Study with Cinnarizine and a Long Chain Self-Nanoemulsifying Drug Delivery System.
    Sassene PJ; Mosgaard MD; Löbmann K; Mu H; Larsen FH; Rades T; Müllertz A
    Mol Pharm; 2015 Nov; 12(11):4067-76. PubMed ID: 26393273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.